Cargando…

Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study

Rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis are chronic progressive immune-mediated rheumatic diseases (IMRD) that can cause a progressive disability and joint deformation and thus can impact in healthcare resource utilization (HCRU) and costs. The main outcome of the study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carballo, Nuria, Garcia-Alzórriz, Enric, Ferrández, Olivia, Navarrete-Rouco, María Eugenia, Durán-Jordà, Xavier, Pérez-García, Carolina, Monfort, Jordi, Cots, Francesc, Grau, Santiago
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667555/ https://www.ncbi.nlm.nih.gov/pubmed/34912219 http://dx.doi.org/10.3389/fphar.2021.752879

Ejemplares similares

Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
por: Carballo, Nuria, et al.
Publicado: (2022)

Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study
por: Carballo, Nuria, et al.
Publicado: (2022)

Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae
por: Sendra, Elena, et al.
Publicado: (2022)

Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona
por: Riu, Marta, et al.
Publicado: (2016)

Incremental cost of nosocomial bacteremia according to the focus of infection and antibiotic sensitivity of the causative microorganism in a university hospital
por: Riu, Marta, et al.
Publicado: (2017)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
por: Svedbom, Axel, et al.
Publicado: (2017)

Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic
por: Grau, Santiago, et al.
Publicado: (2021)

Adherence to Subcutaneous Anti-TNF Treatment in Chronic Inflammatory Rheumatism and Therapeutic Patient Education
por: Fayet, Françoise, et al.
Publicado: (2020)

The Subcutaneous Nodule of Rheumatism
por: Gollerkeri, P. G.
Publicado: (1938)

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
por: Acar, Mustafa, et al.
Publicado: (2018)

Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic
por: Barceló-Vidal, J., et al.
Publicado: (2022)

Reconstituted mRNA COVID-19 vaccines may maintain stability after continuous movement
por: Grau, Santiago, et al.
Publicado: (2021)

Accidental Interruption of the Cold Chain for the Preservation of the Moderna COVID-19 Vaccine
por: Grau, Santiago, et al.
Publicado: (2021)

Diagnostic value of salivary CRP and IL-6 in patients undergoing anti-TNF-alpha therapy for rheumatic disease
por: Sikorska, Dorota, et al.
Publicado: (2018)

Normalization of creatine kinase values in a case of rhabdomyolysis during daptomycin treatment
por: Ferrández, Olivia, et al.
Publicado: (2013)

Assessment of the Physical, Mechanical and Acoustic Properties of Arundo donax L. Biomass in Low Pressure and Temperature Particleboards
por: Ferrandez-García, Maria Teresa, et al.
Publicado: (2020)

Analysis of the Thermal Insulation and Fire-Resistance Capacity of Particleboards Made from Vine (Vitis vinifera L.) Prunings
por: Ferrandez-Villena, Manuel, et al.
Publicado: (2020)

The Influence of Processing and Particle Size on Binderless Particleboards Made from Arundo donax L. Rhizome
por: Ferrandez-Villena, Manuel, et al.
Publicado: (2020)

Study of Waste Jute Fibre Panels (Corchorus capsularis L.) Agglomerated with Portland Cement and Starch
por: Ferrandez-García, Maria Teresa, et al.
Publicado: (2020)

Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections
por: Ferrández, Olivia, et al.
Publicado: (2016)

Impact of Generic Entry on Hospital Antimicrobial Use: A Retrospective Quasi-Experimental Interrupted Time Series Analysis
por: Espona, Mercè, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment
por: Molas, María Ema, et al.
Publicado: (2021)

Characteristics of doripenem: a new broad-spectrum antibiotic
por: Alvarez-Lerma, Francisco, et al.
Publicado: (2009)

Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections
por: Urbina, Olatz, et al.
Publicado: (2013)

A COMPARATIVE STUDY OF SUBCUTANEOUS NODULES IN RHEUMATIC FEVER AND RHEUMATOID ARTHRITIS
por: Dawson, M. H.
Publicado: (1933)

Effects of anti-TNF therapy on ophtalmological complications in children with rheumatic diseases
por: Frkovic, Marijan, et al.
Publicado: (2014)

Anti-TNF-alpha-induced lupus
por: De Bandt, Michel
Publicado: (2019)

HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis
por: Cantini, Fabrizio, et al.
Publicado: (2014)

TNF-alpha Is Required for the Attraction of Mesenchymal Precursors to White Adipose Tissue in Ob/ob Mice
por: Gálvez, Beatriz G., et al.
Publicado: (2009)

Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide
Publicado: (1990)

Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke
por: Cui, Guanglin, et al.
Publicado: (2012)

Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease
por: Navarrete-Dechent, Cristián, et al.
Publicado: (2015)

Glial Tumor Necrosis Factor Alpha (TNFα) Generates Metaplastic Inhibition of Spinal Learning
por: Huie, J. Russell, et al.
Publicado: (2012)

Hospital emergency department utilisation rates among the immigrant population in Barcelona, Spain
por: Buron, Andrea, et al.
Publicado: (2008)

Health Services Utilization, Work Absenteeism and Costs of Pandemic Influenza A (H1N1) 2009 in Spain: A Multicenter-Longitudinal Study
por: Galante, Mariana, et al.
Publicado: (2012)

Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.
por: Kuppen, P. J., et al.
Publicado: (1997)

Circulating TNF-Alpha and IL-6 Concentrations and TNF-Alpha -308 G > A Polymorphism in Children with Premature Adrenarche
por: Utriainen, Pauliina, et al.
Publicado: (2010)

Identification of the Schistosoma mansoni TNF-Alpha Receptor Gene and the Effect of Human TNF-Alpha on the Parasite Gene Expression Profile
por: Oliveira, Katia C., et al.
Publicado: (2009)

Factors for starting biosimilar TNF inhibitors in patients with rheumatic diseases in the real world
por: Sung, Yoon-Kyoung, et al.
Publicado: (2020)

Biological agents targeting beyond TNF-alpha
por: Sharma, Rashmi, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_0094bb89f2kag23tl3ej4088rf